Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Garry Arthur Neil files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Christopher Ryan Sullivan - $3.72M in AVTX purchases and sales in the last 12 months
- Mittie Doyle - $2.98M in AVTX purchases and sales in the last 12 months
- Paul Varki - $1.51M in AVTX purchases and sales in the last 12 months
- Richard M. Wright - $1.18M in CLDX purchases and sales in the last 12 months
- Jonathan Goldman - $163K in AVTX purchases and sales in the last 12 months
- Mitchell Chan - $72K in AVTX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Garry Arthur Neil?
Garry Arthur Neil is a corporate insider of Celldex Therapeutics, Inc. (CLDX). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Garry Arthur Neil last file a Form 4?
The most recent primary Form 4 on record is dated 29 June 2026, one of 4 filings going back to 2026.
